↓ Skip to main content

Monoclonal antibody for reducing the risk of respiratory syncytial virus infection in children

Overview of attention for article published in Cochrane database of systematic reviews, April 2013
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (85th percentile)
  • Good Attention Score compared to outputs of the same age and source (65th percentile)

Mentioned by

twitter
9 tweeters
wikipedia
1 Wikipedia page
f1000
1 research highlight platform

Readers on

mendeley
220 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Monoclonal antibody for reducing the risk of respiratory syncytial virus infection in children
Published in
Cochrane database of systematic reviews, April 2013
DOI 10.1002/14651858.cd006602.pub4
Pubmed ID
Authors

Tea Andabaka, Jason W Nickerson, Maria Ximena Rojas-Reyes, Juan David Rueda, Vesna Bacic Vrca, Bruno Barsic

Abstract

Respiratory syncytial virus (RSV) is one of the most important viral pathogens causing acute respiratory infections in children. It results in about 3.4 million hospitalisations annually in children under five. Palivizumab is an anti-RSV monoclonal antibody, administered intramuscularly at a dose of 15 mg/kg once every 30 days. The efficacy and safety of palivizumab has been evaluated in multicentre, randomised controlled trials (RCTs) and a large number of economic evaluations (EEs) have tested its cost-effectiveness.

Twitter Demographics

The data shown below were collected from the profiles of 9 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 220 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 2 <1%
Canada 2 <1%
France 1 <1%
South Africa 1 <1%
Spain 1 <1%
United States 1 <1%
Unknown 212 96%

Demographic breakdown

Readers by professional status Count As %
Student > Master 42 19%
Researcher 31 14%
Student > Bachelor 29 13%
Student > Ph. D. Student 26 12%
Student > Postgraduate 20 9%
Other 45 20%
Unknown 27 12%
Readers by discipline Count As %
Medicine and Dentistry 105 48%
Nursing and Health Professions 19 9%
Social Sciences 13 6%
Agricultural and Biological Sciences 9 4%
Pharmacology, Toxicology and Pharmaceutical Science 7 3%
Other 27 12%
Unknown 40 18%

Attention Score in Context

This research output has an Altmetric Attention Score of 9. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 31 July 2020.
All research outputs
#2,288,683
of 15,622,115 outputs
Outputs from Cochrane database of systematic reviews
#4,862
of 11,224 outputs
Outputs of similar age
#23,129
of 156,029 outputs
Outputs of similar age from Cochrane database of systematic reviews
#42
of 121 outputs
Altmetric has tracked 15,622,115 research outputs across all sources so far. Compared to these this one has done well and is in the 85th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 11,224 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 23.3. This one has gotten more attention than average, scoring higher than 56% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 156,029 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 85% of its contemporaries.
We're also able to compare this research output to 121 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 65% of its contemporaries.